Experimental Hematology
Volume 37, Issue 9 , Pages 1054-1059 , September 2009

Elevated endothelial progenitor cells during painful sickle cell crisis

  • Rachel T. van Beem

      Affiliations

    • Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands
    • Rachel T. van Beem and Erfan Nur contributed equally to this study.
  • ,
  • Erfan Nur

      Affiliations

    • Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands
    • Department of Haematology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • The CURAMA Study Group, The Netherlands
    • Rachel T. van Beem and Erfan Nur contributed equally to this study.
  • ,
  • Jaap Jan Zwaginga

      Affiliations

    • Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands
    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands
  • ,
  • Precious P. Landburg

      Affiliations

    • The CURAMA Study Group, The Netherlands
    • Immunology Laboratory Department, Red Cross Blood Bank Foundation, Curaçao, The Netherlands Antilles
  • ,
  • Eduard J. van Beers

      Affiliations

    • Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands
    • Department of Haematology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • The CURAMA Study Group, The Netherlands
  • ,
  • Ashley J. Duits

      Affiliations

    • The CURAMA Study Group, The Netherlands
    • Immunology Laboratory Department, Red Cross Blood Bank Foundation, Curaçao, The Netherlands Antilles
  • ,
  • Dees P. Brandjes

      Affiliations

    • Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands
    • The CURAMA Study Group, The Netherlands
  • ,
  • Ingrid Lommerse

      Affiliations

    • Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands
  • ,
  • Hetty C. de Boer

      Affiliations

    • Department of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands
  • ,
  • C. Ellen van der Schoot

      Affiliations

    • Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands
  • ,
  • John-John B. Schnog

      Affiliations

    • The CURAMA Study Group, The Netherlands
  • ,
  • Bart J. Biemond

      Affiliations

    • Department of Haematology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • The CURAMA Study Group, The Netherlands
    • Corresponding Author InformationOffprint requests to: Bart J. Biemond, M.D., Ph.D., Department of Haematology, F4-224, Academic Medical Center, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
  • ,
  • CURAMA Study Group

Received 5 March 2009 ,Revised 6 May 2009 ,Accepted 9 June 2009.

References 

  1. Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007;117:850–858
  2. Jeney V, Balla J, Yachie A, et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood. 2002;100:879–887
  3. Duits AJ, Rodriguez T, Schnog JJ. Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease. Br J Haematol. 2006;134:116–119
  4. Mohan JS, Lip PL, Blann AD, Bareford D, Lip GY. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. Br J Ophthalmol. 2005;89:815–819
  5. Moritani T, Numaguchi Y, Lemer NB, et al. Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography. Clin Imaging. 2004;28:173–186
  6. Kato GJ, Hsieh M, Machado R, et al. Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol. 2006;81:503–510
  7. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593–600
  8. Van Craenenbroeck EM, Conraads VM, Van Bockstaele DR, et al. Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches. J Immunol Methods. 2008;20(332):31–40
  9. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999–1007
  10. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964–3972
  11. Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003;102:1340–1346
  12. Duits AJ, Rojer RA, van Endt T, et al. Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease. Ann Hematol. 2003;82:171–174
  13. Duits AJ, Schnog JB, Lard LR, Saleh AW, Rojer RA. Elevated IL-8 levels during sickle cell crisis. Eur J Haematol. 1998;61:302–305
  14. Serjeant GR, Ceulaer CD, Lethbridge R, Morris J, Singhal A, Thomas PW. The painful crisis of homozygous sickle cell disease: clinical features. Br J Haematol. 1994;87:586–591
  15. Nevskaya T, Bykovskaia S, Lyssuk E, et al. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations. Clin Exp Rheumatol. 2008;26:421–429
  16. Powars DR, Hiti A, Ramicone E, Johnson C, Chan L. Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. Am J Hematol. 2002;70:206–215
  17. Cao J, Mathews MK, McLeod DS, Merges C, Hjelmeland LM, Lutty GA. Angiogenic factors in human proliferative sickle cell retinopathy. Br J Ophthalmol. 1999;83:838–846
  18. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21:37–47
  19. Schnog JJ, Lard LR, Rojer RA, van der Dijs FP, Muskiet FA, Duits AJ. New concepts in assessing sickle cell disease severity. Am J Hematol. 1998;58:61–66
  20. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest. 1982;70:1253–1259
  21. Nath KA, Grande JP, Croatt AJ, et al. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol. 2005;166:963–972
  22. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension. 2005;45:321–325
  23. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 2000;106:411–420
  24. Bahlmann FH, DeGroot K, Duckert T, et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int. 2003;64:1648–1652
  25. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858–864
  26. Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest. 2007;117:1249–1259
  27. Goldstein LJ, Gallagher KA, Bauer SM, et al. Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells. 2006;24:2309–2318
  28. Yang Z, Wang JM, Chen L, Luo CF, Tang AL, Tao J. Acute exercise-induced nitric oxide production contributes to upregulation of circulating endothelial progenitor cells in healthy subjects. J Hum Hypertens. 2007;21:452–460
  29. Heiss C, Wong ML, Block VI, et al. Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J Cell Physiol. 2008;215:366–373
  30. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: A state of nitric oxide resistance. Free Radic Biol Med. 2008;44:1506–1528

PII: S0301-472X(09)00213-6

doi: 10.1016/j.exphem.2009.06.003

Experimental Hematology
Volume 37, Issue 9 , Pages 1054-1059 , September 2009